Saaransh Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 07-07-2024
- Paid Up Capital ₹ 50.00 K
as on 07-07-2024
- Company Age 9 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.95 Cr
as on 07-07-2024
- Satisfied Charges ₹ 1.00 Cr
as on 07-07-2024
- Revenue -24.82%
(FY 2021)
- Profit 2.98%
(FY 2021)
- Ebitda -1.43%
(FY 2021)
- Net Worth 66.97%
(FY 2021)
- Total Assets -11.08%
(FY 2021)
About Saaransh Biotech
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 50.00 K .
The company currently has active open charges totaling ₹4.95 Cr. The company has closed loans amounting to ₹1.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Kanchan Gupta and Rahul Gupta serve as directors at the Company.
- CIN/LLPIN
U74900DL2015PTC286454
- Company No.
286454
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Oct 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
East Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Saaransh Biotech Private Limited offer?
Saaransh Biotech Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antiviral Drugs, Common Disease Medicines, Pharmaceutical Tablets, HIV Drugs, TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Pain Relief Drugs & Pharmaceuticals, Arthritic Drugs, Anti Cancer Injection.
Who are the key members and board of directors at Saaransh Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kanchan Gupta  | Director | 14-Oct-2015 | Current |
| Rahul Gupta | Director | 14-Oct-2015 | Current |
Financial Performance of Saaransh Biotech.
Saaransh Biotech Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 24.82% decrease. The company also saw a slight improvement in profitability, with a 2.98% increase in profit. The company's net worth Soared by an impressive increase of 66.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Saaransh Biotech?
In 2021, Saaransh Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Natasa Infoservices Private LimitedActive 7 years 8 months
Kanchan Gupta and Rahul Gupta are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 25 Feb 2022 | ₹4.95 Cr | Open |
Others Creation Date: 26 Feb 2019 | ₹1.00 Cr | Satisfied |
How Many Employees Work at Saaransh Biotech?
Unlock and access historical data on people associated with Saaransh Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Saaransh Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Saaransh Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
